Tetrahydrocannabinol-C4
| |
| Δ9-Tetrahydrocannabinol-C4
| |
| Systematic (IUPAC) name | |
| (−)-(6aR,10aR)-6,6,9-trimethyl- 3-butyl-6a,7,8,10a-tetrahydro- 6H-benzo[c]chromen-1-ol | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C20H38O2 |
| Mol. mass | 300.43 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Tetrahydrocannabinol-C4, also known as THC-C4 and butyl-THC, is a homolog of tetrahydrocannabinol (THC), the active component of cannabis. They are only different by the pentyl sidechain being replaced by a butyl sidechain. It is unknown whether THC-C4 is an agonist, partial agonist, or antagonist at the cannabinoid receptors. The propyl anolog, THCV is a known antagonist while THC itself is an agonist.
Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added
Pictures
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
